The Impact of Clinical Pharmacist in the Identification and Management of Treatment Related Problems in the Surgery Ward

Not Applicable

Completed

• Conditions: Surgical Patients
• Interventions: Other: clinical pharmacist intervention

• Registration Number: NCT04941820
• Lead Sponsor: University of Jordan

Brief Summary

Patients in the surgery ward are at risk of morbidity and mortality from various types of treatment-related problems (TRPs). The primary aim of this study is to assess the impact of the clinical pharmacist in the identification and management of TRPs in the surgery ward.

Detailed Description

Patients were randomly assigned to intervention (n=50) and usual care (n=50) arms. The clinical pharmacist assessed the types, frequencies, and clinical significance of TRPs for all recruited patients at baseline. Patients and treating surgeons in the intervention arm received recommendations concerning the identified TRPs, while the usual care arm did not. The number of TRPs was reevaluated at follow-up.

Study Timeline

• Study Start: 2019-09-29
• Primary Completion: 2020-02-06
• Study Completion: 2020-02-06
• Status Verified: 2021-06
• Study First Submitted: 2021-06-08
• Study First Submitted QC: 2021-06-25
• Last Update Submitted: 2021-06-25
• Study First Posted: 2021-06-28
• Last Update Posted: 2021-06-28

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

• Admission for elective, urgent, or emergency surgery
• age 18 years or older
• Expected length of stay of 3 days or more in the general surgical ward or the SICU

Exclusion Criteria

• Pregnancy, breastfeeding, drug or alcohol abuse, active malignancy, or admission for plastic surgery

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Clinical pharmacist intervention + usual care arm	clinical pharmacist intervention	Patients in the clinical pharmacist intervention + usual care arm received the clinical pharmacist intervention as well as usual care provided by the surgical team

Primary Outcome Measures

Name	Time	Method
Acceptance rate of clinical pharmacist's recommended interventions	19-week	(Number of recommendations accepted by surgeons) / (total number of recommendations submitted to surgeons by the clinical pharmacist) \*100
The impact of the clinical pharmacist on the identification and management of TRPs in the surgery ward	19-week	Measured by comparing the means of differences in the number of TRPs identified at baseline and at the time of short-term follow-up in the intervention and usual care groups
Implementation rate of clinical pharmacist's recommended interventions	19-week	(Number of recommendations implemented by surgeons and patients) / (total number of recommendations submitted to surgeons and patients by the clinical pharmacist) \*100

Secondary Outcome Measures

Name	Time	Method
Surgeons' attitudes and satisfaction towards the provided clinical pharmacy services	19-week	Measured by a self-administered questionnaire

Trial Locations

Locations (1)

University of Jordan; 🇯🇴 Amman, Jordan